NEVRO CORP.
NVRO
NVRO was delisted on the 2nd of April, 2025.
136 hedge funds and large institutions have $702M invested in NEVRO CORP. in 2023 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 74 increasing their positions, 38 reducing their positions, and 30 closing their positions.
95% more repeat investments, than reductions
Existing positions increased: 74 | Existing positions reduced: 38
2% less call options, than puts
Call options by funds: $6.64M | Put options by funds: $6.8M
12% less funds holding
Funds holding: 155 → 136 (-19)
24% less capital invested
Capital invested by funds: $921M → $702M (-$219M)
63% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 30
Top Buyers
| 1 |
AC
Armistice Capital
New York
|
+$23.5M |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$19.2M |
| 3 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
+$13.9M |
| 4 |
Millennium Management
New York
|
+$11.6M |
| 5 |
Goldman Sachs
New York
|
+$10.1M |
Top Sellers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$33.2M |
| 2 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$12M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$8.47M |
| 4 |
Franklin Resources
San Mateo,
California
|
-$8.17M |
| 5 |
Jennison Associates
New York
|
-$5.53M |
NVRO Hedge Fund Activity: Q3 2023 in Review
136 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in NEVRO CORP. (NVRO) for Q3 2023, worth a combined $702M — down 24% from $921M a quarter earlier.
Sellers outnumbered buyers: 30 funds closed out of NVRO and 11 opened new positions — a net loss of 19 holders — while 38 trimmed existing stakes and 74 added.
The largest buyer was Armistice Capital, adding an estimated $23.5M. The largest seller was Fidelity Investments, cutting an estimated $33.2M.
- 136 institutional investors held NEVRO CORP. (NVRO) as of Q3 2023, down from 155 in Q2 2023.
- Funds reported $702M of NEVRO CORP. stock for Q3 2023, down 24% quarter-over-quarter.
- 11 funds opened new NEVRO CORP. positions in Q3 2023 and 30 closed out, a net change of -19 holders.
- The largest NEVRO CORP. buyer in Q3 2023 was Armistice Capital, an estimated $23.5M added.
- The largest NEVRO CORP. seller in Q3 2023 was Fidelity Investments, an estimated $33.2M sold.
Based on aggregated 13F filings for Q3 2023.